Safe People
Lead applicant organisation name	Aston University

Safe Projects
Project title	SGLT2i use in patients with diabetes and chronic kidney disease - A retrospective audit
Lay summary	Type 2 diabetes is a common condition affecting 4 million people in the United Kingdom. Chronic kidney disease is a well-known long term complication of diabetes and affects nearly 40% of all people with diabetes. It is a progressive condition and can lead to kidney failure requiring dialysis. Diabetes is a leading cause of renal failure and each year costs the NHS up to 2 billion pounds. The presence of kidney disease also increases the risk of heart attacks and stroke and carries up to 5 times risk of death when compared to those who do not have diabetes.
Public benefit statement	There are multiple benefits that could arise from this work. 1. The audit will identify the proportion of patients who are eligible for this treat mane as per NICE recommendations and those actually receiving it. 2. It will help modifying existing clinical pathways to improve access to all eligible patients 3. Early intervention can reduce the risk of kidney disease progression 4. Identify the extent of adverse effects that may arise from the treatment in a real world setting 5. Reduce NHS costs in the long term
Latest approval date	29/07/2024

Safe Data
Dataset(s) name	PATHWAY Research Data Hub: PWY011 dataset

Safe Setting
Access type	Data Licence Agreement between the collaborating organisations using secure and controlled data analysis environments.

Safe Outputs
Link	Not yet Published